Jordan Simons
Director/Board Member at Playsino, Inc.
Profile
Mr. Jordan Simons is Managing Partner at GCP, Inc. He is on the Board of Directors at Playsino, Inc.
Mr. Simons was previously employed as Founder by US WorldMeds LLC.
Jordan Simons active positions
Companies | Position | Start |
---|---|---|
Playsino, Inc.
Playsino, Inc. Packaged SoftwareTechnology Services Playsino, Inc. develops gaming software solutions. It offers gaming companies an effective and complete gaming platform which enables skill-based matchmaking, tournaments and points or cash competitions. The company was founded by Francisco Diaz-Mitoma and Brock Pierce in 2006 and is headquartered in Beverly Hills, CA. | Director/Board Member | - |
Former positions of Jordan Simons
Companies | Position | End |
---|---|---|
MDD US Operations LLC
MDD US Operations LLC Pharmaceuticals: MajorHealth Technology MDD US Operations LLC engages in the of development of phaamaceutical products. Its product portfolio include apomorphine hydrochloride, nadolol, iofexidine, rimabotulinumtoxinB, dantrolene sodium, and safinamide. The company was founded by Paul Breckinridge Jones on March 23, 2001 and is headquartered in Louisville, KY. | Corporate Officer/Principal | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
Playsino, Inc.
Playsino, Inc. Packaged SoftwareTechnology Services Playsino, Inc. develops gaming software solutions. It offers gaming companies an effective and complete gaming platform which enables skill-based matchmaking, tournaments and points or cash competitions. The company was founded by Francisco Diaz-Mitoma and Brock Pierce in 2006 and is headquartered in Beverly Hills, CA. | Technology Services |
MDD US Operations LLC
MDD US Operations LLC Pharmaceuticals: MajorHealth Technology MDD US Operations LLC engages in the of development of phaamaceutical products. Its product portfolio include apomorphine hydrochloride, nadolol, iofexidine, rimabotulinumtoxinB, dantrolene sodium, and safinamide. The company was founded by Paul Breckinridge Jones on March 23, 2001 and is headquartered in Louisville, KY. | Health Technology |
- Stock Market
- Insiders
- Jordan Simons